Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cell Impact has been awarded silver medal by EcoVadis

EcoVadis is the world’s most trusted provider of business sustainability ratings and has recently awarded Cell Impact AB a silver medal.EcoVadis’ thorough evaluation of Cell Impact’s operational sustainability practices has resulted in a rating of 72/100 and thus placed Cell Impact in the top 94 percent among all companies rated in the past year – 46 percent above the industry average. “The EcoVadis rating validates and demonstrates our commitment to sustainability and supports our company mission to help transform the global energy system and reduce the world's dependency on fossil

Presentation of Probi’s Q2 Report 2024

Probi’s report for the second quarter 2024 will be published on Tuesday, 16 July at 8.00 a.m. CET. In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Anita Johansen and CFO Per Lindblad will present and comment on the report. The presentation and presentation material can be obtained via www.probi.com or https://ir.financialhearings.com/probi-q2-report-2024 

BioStock: PHI aims for US listing

Swedish Medtech Phase Holographic Imaging is making significant strides in the United States, establishing itself at the forefront of the rapidly growing regenerative medicine field. PHI is now taking an important step by applying for listing its shares in the US OTCQB market to enhance its presence and opportunities in the US. BioStock talked to CEO Patrik Eschricht to learn more about what this means for the company.Read the full article at biostock.se : https://www.biostock.se/2024/07/phi-aims-for-us-listing/ This is a press release from BioStock -

Distinct T-cell signatures observed at different stages of type 1 diabetes development

A study conducted at the University of Eastern Finland found distinct signatures in CD8-positive T cells in blood samples from children with newly diagnosed type 1 diabetes and in autoantibody-positive children who later developed type 1 diabetes. The study was published in the journal Diabetes. Type 1 diabetes is an autoimmune disease which usually develops in childhood. The symptomatic onset of type 1 diabetes results from a T-cell mediated destruction of insulin-producing beta cells in the pancreas. CD4-positive helper T cells orchestrate the autoimmune response, while CD8-positive

Aquaporin secures order with large EMEA water treatment company

Aquaporin is pleased to announce that it has secured an order valued at USD 300,000 from a large water treatment company in the EMEA region. This latest order comes from a recurring customer specializing in treating industrial wastewater, underscoring the strong, ongoing partnership between the two companies.The customer serves various market segments, including industries such as semiconductors, industrial plants, pharmaceuticals, and sewage treatment. The order consists of a variety of membrane modules from the CLEAR series, but predominantly CLEAR Classic 8040 and CLEAR Classic 4040. "

Re: Dividend Payment

For Immediate Release:       11 July 2024 ARK INVEST UCITS ICAV Re: Dividend Payment   The Directors of ARK INVEST UCITS ICAV (the “Fund”) wish to announce the following dividend paid by the Fund for the semi-annual dividend. Announcement Date: 11 July 2024 Ex-Date:  18 July 2024 Record Date:  19 July 2024 Payment Date:  30 July 2024   +------------------------+------------+--------+----------------+|Sub-Fund/Share Class |ISIN |Currency|Amount per Share|+------------------------+------------+--------+----------------+|RIZE GLOBAL SUSTAINABLE

Interim report January – June 2024: Continued strong profit and high rate of acquisitions

During the period, operational and financial progress remained strong due to rent increases, new development projects, new and extended rental contracts and positive acquisition effects.· Rental income increased by 19%, amounting to SEK 335 m (280). · Net operating income increased by 23%, amounting to SEK 286 m (232). · Profit from property management increased by 26% and amounted to SEK 182 m (145). · Earnings per share amounted to SEK 1.45 (0.65). · Net asset value (NAV) per share increased by 7% in the period and amounted to SEK 26.97. · Value changes in investment

John Mattson enters unique partnership with Stockholm Exergi to help with the transition of Stockholm’s energy system

Property company John Mattson and the energy company Stockholm Exergi have entered an agreement aimed at securing the long-term supply of district heating to John Mattson’s property portfolio and with the shared objective of reaching net zero for district heating production for the Stockholm region. The partnership entails investment by John Mattson in Stockholm Exergi’s transition of district heating over a longer period. At the same time, John Mattson is securing the supply of cost-effective and sustainable district heating for its properties.John Mattson’s investment will support

Notification of major holding in Kindred Group plc

Kindred Group plc (Kindred) hereby announces that it, on 10 July 2024, has received a notification of major holding from JPMorgan Chase & Co, a company with its registered office in Wilmington, Delaware, USA. The notification refers to a decrease in the number of shares and voting rights in Kindred held by JPMorgan Chase & Co.According to the notification, JPMorgan Chase & Co held 4.89% of the shares and voting rights in Kindred as of 05 July 2024. The relevant chain of controlled undertakings can be found in the notification, of which a copy can be found on Kindred’s website: https://

Faron Announces Positive FDA Feedback

Faron Pharmaceuticals Ltd.   (“Faron” or the “Company”)     Inside Information: Faron Announces Positive FDA Feedback   Company announcement, Inside Information, 11 July 2024 at 7:00 a.m. BST / 9:00 a.m. EEST   Key highlights -          Faron had a formal meeting with the FDA to discuss the registrational clinical development plan for bexmarilimab in the treatment myelodysplastic syndrome (MDS). -          The FDA acknowledged the difficulties of running a randomized study with a comparator in the relapsed / refractory setting (r/r) and instead proposed that

Implantica announces new health-economics data publication showing RefluxStop™’s superior cost-effectiveness for the Swiss healthcare system

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, reports the study, “Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease,” was published recently by the Journal of Medical Economics %20is,MSA%5D)%20in%20selected%20cases)1.The comprehensive health economic analysis published in this study found that RefluxStop™ is highly likely to be a cost-effective treatment for GERD

ForCrowd European Licence

11 July 2024 Quantum Blockchain Technologies Plc (”QBT” or “the Company”)     Forcrowd Update   The Board of Quantum Blockchain Technologies (AIM: QBT) is pleased to provide an update on its investee company, Forcrowd Srl ("Forcrowd"), the Italian equity-crowdfunding platform, in which it holds a 41% stake.   Forcrowd has recently secured registration with the European Securities and Markets Authority (“ESMA”) as an authorised provider of crowdfunding services per Regulation (EU) 2020/1503 with resolution 23169. This registration was achieved through a rigorous

High customer activity and strong results

DNB’s profit in the second quarter of 2024 was NOK 10.8 billion. This is NOK 1.3 billion, or 13.8 per cent, higher than the corresponding quarter of last year. The results were strong in all customer segments, and were supported by a stable Norwegian economy, with low unemployment and a higher activity level than expected.  Residential property prices have increased by 8 per cent so far this year. At the same time, the market for sale of new builds appears to have bottomed out, and several players in the sector will be working on new housing projects in the time ahead. “Increasing

Sweco wins SEK 400 million contract from the Swedish Transport Administration for project planning of a new railway along parts of the East Coast Line between Uppsala and Stockholm

Sweco will assist the Swedish Transport Administration with various consulting services to enable an extensive expansion of stretches of the East Coast Line between Uppsala and Stockholm. The order value for Sweco is estimated at about SEK 400 million. The contract, which will run from 2024 until 2035, will comprise project planning in railways, roads and road structures, building construction, architecture, water and sewage as well as consulting in environmental and digital solutions. The aim of the expansion “Four tracks Uppsala 

Read original

A year of innovation to continue Ovako’ s sustainability journey

Ovako has published its Sustainability Report  for the Financial Year 2023, demonstrating its continued leadership in sustainability, and inviting partners to join in collaborative efforts towards a sustainable society.On average Ovako’s steel products consist of 97 percent recycled steel. Since 2015, Ovako has reduced its carbon emissions per tonne steel from operations with 56 percent and the “cradle-to-gate” carbon footprint from Ovako’s steel products is 80 percent lower than the global average. The Sustainability

Read original

Hydrogen flight looks ready for take-off with new advances

The possibility of hydrogen-powered flight means greater opportunities for fossil-free travel, and the technological advances to make this happen are moving fast. New studies from Chalmers University of Technology, in Sweden, show that almost all air travel within a 750-mile radius (1200 km) could be made with hydrogen-powered aircraft by 2045, and with a novel heat exchanger currently in development, this range could be even further.   “If everything falls into place, the commercialisation of hydrogen flight can go really fast now. As early as 2028, the first commercial

Vår Energi: Second quarter and first half 2024 trading update

Sandnes, Norway, 11 July 2024: Vår Energi ASA (OSE: VAR, the "Company") will publish its financial report for the second quarter and first half 2024 on Tuesday 23 July. Today, the Company provides an update on production, sales volumes and other relevant items. The average production of 293 kboepd in the first half of 2024 is in the upper end of the guided range for the period and the Company is on track to meet the full year production guidance of 280 to 300 kboepd. Net production of oil, liquids and natural gas averaged 287 kboepd for the second quarter of 2024, a decrease of 4%

Inside information: Profit warning - Terveystalo raises its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the second quarter of 2024

Terveystalo Plc, inside information 11 July 2024 at 08:00 EEST The implementation of Terveystalo's profit improvement program has progressed faster during the first half of the year than originally expected, and Terveystalo raises its profitability guidance for 2024.  The guidance for revenue remains unchanged. - Our profit improvement measures have had a faster impact than expected and our profitability strengthened even during the seasonally lower demand in the summer. The fifth consecutive quarter of profit improvement and Q2 results underline that the turnaround objectives set

Australian Streaming Market Faces Turbulence Amid Subscriber Shake-Ups

Simon-Kucher’s 2024 Global Streaming Study reveals that streaming services face unprecedented demand for unique content opportunities[Sydney, July 10, 2024] – Simon-Kucher, a leading global growth consultancy, has released its 2024 Global Streaming Study. Showing increased screentime and more subscriptions per user, the study finds that the Australian streaming market remains strong. Significant shifts are visible in subscription dynamics and content preferences. “Streaming is at a fascinating crossroads,” said Chris Petzoldt, Managing Director Simon-Kucher Oceania. “Number of

Leqembi approved for the treatment of Alzheimer’s disease in Hong Kong

Stockholm, Sweden, July 11, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Department of Health in Hong Kong has approved Leqembi® (brand name in Hong Kong: “樂意保®”, generic name: lecanemab) for treatment of Alzheimer’s disease (AD). Treatment with Leqembi should be initiated in patients with mild cognitive impairment (MCI) or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. Hong Kong is the fifth approval following the US, Japan, China and South Korea.Leqembi’s approval in Hong Kong is based

Lundin Mining Publishes 2023 Sustainability Report

VANCOUVER, BC, July 10, 2024 /CNW/ - (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) is pleased to announce the publication of its 2023 Sustainability Report (the “Report”) which highlights the Company’s material environment, health & safety, governance and social performance during the year. Jack Lundin, President and CEO, commented "We are pleased to present our annual Sustainability Report, which highlights Lundin Mining’s commitment to responsible and sustainable practices within the mineral resource industry. This report is integral to

BlueNord: Option Exercise - Issue of New Shares

Oslo, 10 July 2024: BlueNord ASA ("BlueNord" or the "Company") announces that a former member of the Company's board of directors has exercised 50,000 options and a former member of the Company’s management has exercised 22,000 options at a strike price of NOK 160 per share. As a result of the exercise, the Company will deliver 72,000 new shares. The board of directors has consequently resolved to issue 72,000 new shares at a subscription price of NOK 160 per share, pursuant to the authorisation to the board to issue new shares as granted by the Company's annual general meeting on 14 May

SmartCraft ASA (SMCRT) - Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back programme for SmartCraft ASA (“SmartCraft”) (Ticker: SMCRT NO). Date on which the share buy-back programme was announced: 7 May 2024. The duration of the buy-back programme: 7 May 2024 until no later than the day before the Issuer's Annual General Meeting in 2025. Size of the buy-back programme: Maximum consideration of NOK 15,000,000. From 2 July 2024 until 10 July 2024, SmartCraft has purchased a total of 28,757 own shares at an average price of NOK 29.9571 per share. Aggregated overview of

There are no items matching the current filter
There are no more items matching the current filter
Back to top